Screener
Vertex Pharmaceuticals VRTX Market capitalization
Market capitalization at other companies
Other financials
Where this comes from
Computed from the period-end share price: $126.07B.
The source filing: Vertex Pharmaceuticals’s 8-K, filed August 3, 2026. Open the filing →
- Filed
- Aug 3, 2026, 4:09 PM EDT
- Accession
- 0000875320-26-000256
FAQ
- What is Vertex Pharmaceuticals's market capitalization?
- Vertex Pharmaceuticals (VRTX) reported market capitalization of $126.07B in Q2 2026.
- How has Vertex Pharmaceuticals's market capitalization changed year-over-year?
- Vertex Pharmaceuticals's market capitalization increased by 9.0% year-over-year, from $115.63B to $126.07B.
- What is the long-term trend for Vertex Pharmaceuticals's market capitalization?
- Over 5 years (2020 to 2025), Vertex Pharmaceuticals's market capitalization has grown at a 13.9% compound annual growth rate (CAGR), from $60.09B to $115.03B.
- What does market capitalization mean?
- The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.
Ask your AI about Vertex Pharmaceuticals's market capitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude